CRO Health Decisions Names Andrea Lukes, MD, FACOG, CMO 2017-10-03T21:26:21-05:00

Project Description

CRO Health Decisions Names Andrea Lukes, MD, FACOG, Chief Medical Officer

Leading women’s health CRO Health Decisions names distinguished OB/GYN Andrea S. Lukes Chief Medical Officer

Andrea S. Lukes, MD, FACOG, Health Decisions CMODurham, North Carolina. Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, today announced the appointment of Andrea Lukes, MD, as Chief Medical Officer. A board-certified obstetrician and gynecologist with extensive experience in clinical research, Dr. Lukes will provide therapeutic leadership and insight to ensure effective planning and execution of Health Decisions’ clinical trials of novel women’s health products and diagnostics for all therapeutic areas.

“Health Decisions is delighted to add Andrea’s therapeutic expertise and her understanding of key issues in the clinical development of women’s health products to our leadership team,” said Patrick Phillips, D. Phil., Health Decisions’ Chief Executive Officer. “Health Decisions and our trial sponsors will benefit greatly from Andrea’s experience conducting and overseeing clinical trials and advising sponsors on the development of products to address a wide range of women’s health conditions.”

“I look forward to the opportunity at Health Decisions and plan on making a positive impact on the development of new products to improve health outcomes for women worldwide,” Dr. Lukes said. “Despite recent advances, many women have significant unmet medical needs. It is exciting to join the leadership team in an organization focused on addressing those needs in women’s health.”

Extensive Experience in Clinical Trials of Women’s Health Drugs and Devices

An experienced principal investigator in industry-sponsored, NIH and CDC clinical trials, Dr. Lukes has conducted or overseen more than 80 clinical trials of investigational women’s health products, including both drugs and devices, in the last ten years. She has published extensively in leading obstetrics and gynecology journals. In addition, she has served on advisory committees for FDA meetings on the clinical development of a variety of women’s health products.

Dr. Lukes founded the Carolina Women’s Research and Wellness Center (CWRWC), a research center focused on women’s health. She established the Women’s Wellness Clinic, a leading private gynecologic practice and clinical research center within CWRWC. Dr. Lukes co-founded and served as the Director of Gynecology for the Women’s Hemostasis and Thrombosis Clinic at the Duke University Medical Center. She also founded and chaired the OB/GYN Alliance, an online network of 8,000 OB/GYN physicians in the United States. Dr. Lukes received a bachelor’s degree and a combined medical degree and master’s degree in statistics from Duke University. She completed her residency at the University of North Carolina School of Medicine.

About Health Decisions

Health Decisions is a full-service CRO offering therapeutic, operational and regulatory excellence for clinical development of drugs, diagnostics, medical devices and combination drug/devices in all areas of women’s health. Based on therapeutic and operational experience and investigator relationships developed in studies conducted over the past 28 years, Health Decisions successfully addresses the challenges of developing products in areas including reproductive and sexual health, menopause, pain management, osteoporosis/osteoarthritis, reproductive psychiatry, gynecologic oncology and general gynecology indications. If it matters to women’s health, it matters to Health Decisions. Health Decisions is headquartered in Durham, NC.
# # #

Media Inquiries
Health Decisions
Leslie Hammill
Senior Marketing Specialist
+1 919.967.1111 ext. 520
lhammill @